-
Hymon® IDH1, IDH2 and FLT3 Gene Mutation Detection Kit
Targeted medication for acute myeloid leukemia. Confirmed mutation: recommended medications include ivosidenib, enasidenib, gilteritinib, midostaurin
-
Hymon® BRAF Gene Mutation Detection Kit
Targeted medication for non-small cell lung cancer and melanoma. Confirmed mutation: recommended medications include dabrafenib, vemurafenib, trametinib, etc.
-
Hymon® RET Gene Mutation Detection Kit
Targeted medication for non-small cell lung cancer. Confirmed mutation: recommended medications include pratinib, selpercatinib,
etc. -
Hymon® Met Gene Mutation Detection Kit
Targeted medication for non-small cell lung cancer. Confirmed mutation: recommended medications include savolitinib, gumetinib, etc.
-
Hymon® ROS1 Fusions Gene Detection Kit
Targeted medication for non-small cell lung cancer. Confirmed mutation: recommended medications include emtricinib, crizotinib, ceritinib, etc.
-
Hymon® EML4-ALK Fusion Gene Detection Kit
Targeted medication for non-small cell lung cancer. Confirmed mutation: recommended medications include crizotinib, ceritinib, alectinib, etc.
-
Hymon® EGFR Gene Mutation Detection Kit
Targeted medication for non-small cell lung cancer. Confirmed mutation: recommended medications include gefitinib, afatinib, dacomitinib, erlotinib, osimertinib, etc.
-
Hymon® KRAS Gene Mutation Detection Kit
Targeted medication for colorectal cancer. Confirmed mutation: the patient is not suitable to use cetuximab or panitumumab.
-
Hymon® SARS-CoV-2 Test Kit
Hymon® SARS-CoV-2 Test Kit provides in vitro detection of the coronavirus SARS-CoV-2 in nasopharyngeal/oropharyngeal swab and other respiratory samples. The virus infects human and causes COVID-19.
This test kit has received US FDA Emergency Use Authorization and European Union CE Certificate.
-
Hymon® MULTONE™ Monkeypox Test Kit
Hymon® provides a quantitative PCR MULTONETM Monkeypox Test Kit for quick and sensitive detection of Monkeypox virus. This kit can detect specific nucleic acid fragments of the virus with Hymon’s innovative “one-step” method as fast as 30 minutes from sample to results. The reagent uses the company’s unique MoLock and DIDC technology, suitable for accurate diagnosis of related diseases. It has the characteristics of fast detection, high sensitivity, and high specificity, and is compatible with conventional fluorescent PCR platforms.
-
Nucleic Acid Extraction Kit (Solid Phase Matrix Method)
The reagent can be used to purify nucleic acids in whole blood, swab samples and other body fluid samples. This product mainly provides purified high-quality nucleic acid for downstream nucleic acid amplification experiments or other enzyme kinetics experiments.
-
Hymon® COVID-19 Antigen Rapid Test Kit
Hymon® COVID-19 antigen rapid test kit is a lateral flow immunoassay for the qualitative detection of SARS-COV-2 antigen (nucleocapsid protein) with nasal swabs or saliva during the acute phase of infection. It only takes 15 minutes to complete the test and non-invasive. Negative results do not rule out SARS CoV-2 infection, and should not be used as the sole basis for treatment. Molecular assay may be performed if necessary.
